Superior Mesenteric Artery Thrombosis in COVID-19-Positive Patients: A Rare Coincidence


Rushabh Parekh • Virendra Athavale • Saili Kelshikar, Published: June 11, 2024 DOI: 10.7759/cureus.62136  Abstract Since the start of the SARS-CoV-2 pandemic, which is otherwise known as the worldwide coronavirus disease, 2019, has had a well-established pro-thrombotic character. Patients often first exhibit respiratory symptoms, and those whose severity increases eventually develop acute hypoxic respiratory failure. The systemic hypercoagulable condition and arterial/venous […]

COVID Severity Not Affected By Viral Load Upon First Infection: Study


TUESDAY, JUN 11, 2024 – Authored by Marina Zhang via The Epoch Times  The viral load or quantity of SARS-CoV-2 in the nasal cavity does not predict disease severity, according to a recent JAMA Network Open study. “We observed considerable variability in VL (viral load) at diagnosis,” the authors wrote. “Intriguingly, we did not find an association between […]

Coronavirus Disease Olfactory Dysfunction: A Randomized Controlled Trial


Alex Zxi Jian Ho • Nur Izzati B. Ishak • Eugene Hung Chih Wong, Published: June 06, 2024,DOI: 10.7759/cureus.61855  Abstract Introduction Persistent olfactory dysfunction was seen in many patients upon coronavirus disease 2019 (COVID-19) infection recovery. However, research on its management was very limited, especially among the Southeast Asian population. Objectives We aim to investigate the role of olfactory rehabilitation and […]

Acute Encephalitis During a SARS-CoV-2 Infection: A Case Report


Yousfi Samah • Ansam Milhi • Sanae Elhasnaoui • Yassine Mebrouk, Published: June 09, 2024DOI: 10.7759/cureus.62009  Abstract It was in December 2019 that the coronavirus causing COVID-19 was first detected in Wuhan, China. Although the primary clinical presentation is respiratory disease, an increasing number of reports worldwide have noted various neurological manifestations, such as acute encephalitis. We present a case of a 49-year-old […]

COVID-19 Presenting as Encephalitis and Myopericarditis: A Report of a Rare Case


Nikolaos Kakaletsis • Ioannis Alevroudis • Serafeim-Chrysovalantis Kotoulas •et. al., Published: June 10, 2024, DOI: 10.7759/cureus.62056  Abstract COVID-19 might present with a wide range of clinical manifestations, from mild respiratory distress to severe multi-organ dysfunction. We present a unique case of complex COVID-19 presentation in a 45-year-old female who initially developed general symptoms such as fever, cough, headache, and weakness, which escalated […]

ANALYSIS: What 9th Circuit Ruling Reinstating Challenge to LAUSD’s Employee Vaccine Mandate Means


y Jennifer Van Laar | 4:27 PM on June 08, 2024, The opinions expressed by contributors are their own and do not necessarily represent the views of RedState.com. In a split decision, a three-judge panel from the Ninth Circuit Court of Appeals issued a ruling Friday afternoon reversing the dismissal of a lawsuit filed by Los Angeles Unified […]

CDC Figures Show COVID At “Very High” Levels In 7 US States


FRIDAY, JUL 19, 2024 – Authored by Jack Phillips via The Epoch Times, The most recent wastewater data published by the U.S. Centers for Disease Control and Prevention (CDC) show that COVID-19 levels are “very high” in about a half-dozen states and at “high” levels in even more. As of the agency’s most recent update, about […]

Association of Initial Viral Load in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients with Outcome and Symptoms


Kimon V. Argyropoulos,∗ Antonio Serrano,∗ Jiyuan Hu,† et. al., Am J Pathol. 2020 Sep; 190(9): 1881–1887. doi: 10.1016/j.ajpath.2020.07.001PMCID: PMC7332909PMID: 32628931 Abstract The dynamics of viral load (VL) of the severe acute respiratory syndrome coronavirus 2 and its association with different clinical parameters remain poorly characterized in the US patient population. Herein, we investigate associations between VL and parameters, such as severity of […]

Extending Paxlovid Not Effective Against Long COVID


Friday, 07 June 2024 Newsmax Health An extended course of the antiviral drug Paxlovid won’t ease a person’s long COVID symptoms, a new study finds. People who took Paxlovid for 15 days — three times as long as it’s prescribed for an initial COVID infection — had no better improvement in their long COVID than people taking a placebo, […]